0 Members and 1 Guest are viewing this topic.
company trump awarded $1.3B has produced nothingThe Trump admin awarded a firm up to $1.3 billion to make Covid vaccine syringes. Where are they?WASHINGTON — A year after a Connecticut company was awarded federal loans and contracts worth up to nearly $1.3 billion to supply an essential syringe for the Covid-19 vaccine rollout, no syringes have been made. The syringe hasn't received even the first of a series of approvals it needs from the federal government before it can be manufactured, and a factory promising 650 jobs remains unbuilt.ApiJect Systems Corp. positioned itself as the company that would make the difference between a stumbling rollout and delivery of lifesaving vaccines. But as the U.S. vaccine rollout hits full stride, with about half of adults in the U.S. having already received at least one injection, the need for ApiJect's device has waned, leaving the contracts and loans in question.The company said in a statement to NBC News that it "is working with several vaccine pharmaceutical companies to conduct the testing and regulatory reviews of Covid-19 vaccines in the ApiJect syringe."Full coverage of the coronavirus outbreakHowever, a spokesperson for Pfizer, one of the vaccine makers, said that even if ApiJect's syringe got all the necessary approvals from the Food and Drug Administration, it would "not have any impact on our output or process." Moderna didn't respond to a request for comment, and Johnson & Johnson declined to comment.According to ApiJect, it has “packaged … for testing purposes, two of the vaccines” so the vaccine companies can do the tests required before requesting FDA approval to use the syringe with their products. Neither federal regulators nor any of the vaccine makers would confirm any pending approval requests. ApiJect didn't provide the names.
dude, sell me your TACO if you are broke.. i will pay $8k cash manvirus are hard time for somefolksi need a truck to go fishingWIN WIN
Bring me 8K this weekend, ok?
Lol all hat, all cattle here